Drugs / Zirconium silicate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01493024 | Nov 2011 → May 2012 | chronic kidney disease, impaired renal function disease | ZS Pharma, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zirconium silicate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01493024 ↗ |
| Modality | Other / unclassified | “an oral sorbent” NCT01493024 ↗ |
| Route | Oral | “an oral sorbent” NCT01493024 ↗ |